Status:

COMPLETED

Surgery for Recurrent Intrahepatic Cholangiocarcinoma

Lead Sponsor:

Chang Gung Memorial Hospital

Conditions:

Cholangiocarcinoma, Intrahepatic

Recurrence Cholangiocarcinoma

Eligibility:

All Genders

18-75 years

Brief Summary

The investigators retrospectively reviewed the participants suffering from recurrent intrahepatic cholangiocarcinoma after curative resection and aimed to explore the predictive factors for recurrence...

Eligibility Criteria

Inclusion

  • R0 resection for intrahepatic cholangiocarcinoma at initial diagnosis.

Exclusion

  • (1)Patient with R1 or R2 resection
  • (2)Distant metastasis noted when laparotomy
  • (3)Surgical mortality

Key Trial Info

Start Date :

June 1 2017

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 30 2018

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT04072250

Start Date

June 1 2017

End Date

October 30 2018

Last Update

September 13 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Chang Gung Memorial Hospital Linkou Branch

Taoyuan District, Taiwan, 333